tiprankstipranks

GB:HEAL ETF Price & Analysis

Compare

HEAL ETF Chart & Stats

ETF Overview

iShares Healthcare Innovation UCITS ETF

The iShares Healthcare Innovation UCITS ETF (ticker: BLKIF) is a dynamic investment vehicle designed to capture the cutting-edge advancements within the healthcare sector. This ETF is meticulously crafted for investors who seek exposure to the burgeoning field of healthcare innovation, a niche that is redefining the future of medical technology and patient care. As a sector-focused fund, BLKIF zeroes in on companies at the forefront of medical breakthroughs, including biotechnology firms, medical device manufacturers, and digital health pioneers that are revolutionizing the way healthcare is delivered and experienced. The iShares Healthcare Innovation UCITS ETF offers a diversified approach, enabling investors to tap into a broad-based niche where science meets technology to tackle some of the most pressing health challenges of our time. By concentrating on firms that are leveraging innovation to drive growth and impact, this ETF provides an opportunity to invest in the future of healthcare, all while benefiting from the potential economic upside that these transformative companies offer. Managed under the renowned iShares brand, BLKIF is structured to provide both growth potential and resilience, making it a compelling choice for those looking to align their portfolios with the technological evolution in healthcare. Whether you're a seasoned investor or new to the market, the iShares Healthcare Innovation UCITS ETF represents a strategic pathway to harness the power of innovation within one of the most vital sectors in the global economy.

iShares Healthcare Innovation UCITS ETF (HEAL) Fund Flow Chart

iShares Healthcare Innovation UCITS ETF (HEAL) 1 year Net Flows: -$107M

HEAL ETF FAQ

What was GB:HEAL’s price range in the past 12 months?
GB:HEAL lowest ETF price was $7.00 and its highest was $8.20 in the past 12 months.
    What is the AUM of GB:HEAL?
    As of Feb 28, 2025 The AUM of GB:HEAL is 1.05B.
      Is GB:HEAL overvalued?
      According to Wall Street analysts GB:HEAL’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does GB:HEAL pay dividends?
        GB:HEAL does not currently pay dividends.
        How many shares outstanding does GB:HEAL have?
        Currently, no data Available
        Which hedge fund is a major shareholder of GB:HEAL?
        Currently, no hedge funds are holding shares in GB:HEAL

        HEAL ETF Smart Score

        For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

        Top 10 Holdings

        Name
        Weight %
        Gilead Sciences
        2.63%
        ARGX
        arGEN X
        2.57%
        Natera Inc.
        2.12%
        Insulet
        2.12%
        Bristol-Myers Squibb Company
        2.08%
        Intuitive Surgical
        2.05%
        UCB
        UCB SA
        2.03%
        Boston Scientific
        1.99%
        Abbott Laboratories
        1.96%
        207940
        SAMSUNG BIOLOGICS Co., Ltd.
        1.94%
        Total21.48%
        See All Holdings
        Popular ETFs
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis